Dr. Coleman Presents State of Stem Cell Therapy in the U.S.

Dr. Jack Coleman, M.D. recently talked about the state of stem cell therapy in the U.S. at the International Congress on Stem Cell Research in Italy. Dr. Coleman is with the Lung Institute and works to find new ways to improve the quality of life for people with various lung diseases. He claims that stem cell therapies are becoming more popular with treating lung diseases, however, in the U.S. the process of introducing a new medicine or medical procedure takes too long to reach the market. Medicines are bogged down by regulations, making them very expensive, if they every do make it to patients.

In a report by Hawaii News, Dr. Coleman looks at the way the U.S. functions versus other countries, to see how things may be improved. He talks about how the intense regulations and expense of introducing medicine in the laboratory through trials and getting it to patients is outdated and antiquated. Dr. Coleman and other speakers at the event talked about various aspects of stem cell therapy and research including the ethical implications and the various groups close to the stem cell issue. Some of these include researchers, the Catholic Church, physicians and patients.

The recent theme was “From Cells to Cell Products. Development of New Therapeutic Tools.” Dr. Coleman emphasizes the fact that most stem cell research is funded by biotechnology companies and the U.S. Government. Much of the research is therefore under government control. These expenses are then passed on to consumers and insurance companies. Dr. Coleman stresses that the costs may not be passed on fairly. This causes patients to look for treatments in areas that are not under so much regulation and may not be as safe or effective. He claims that researcher’s responsibility is to give the best, safest treatment to patients to relieve pain and provide a good quality of life.

The Lung Institute promotes stem cell therapy (https://lunginstitute.com/treatment/) for lung diseases like chronic obstructive pulmonary disease, pulmonary fibrosis and other lung diseases in the U.S. The Lung Institute has treated over 3000 patients with various lung ailments. A study showed that most patients treated showed an improvement in their quality of life. The Institute opened in Tampa, Florida in 2013. There are currently clinics in Nashville, Scottsdale, Pittsburgh and Dallas. For more information, visit lunginstitute.com.

Lung Institute on Facebook: https://www.facebook.com/LungInstitute/